点击↗↗↗关注，等的就是你！

The globalAPI market will achieve a CAGR of 6.8% running up to 2026, taking the totalvalue to $268bn, a report suggests.

一份报告显示，到2026年，全球API市场的复合年增长率将达到6.8%，总价值将达到2680亿美元。

The market was valued at $176.3bn(€155bn) in 2018 and is expected to witness sustained growth through 2026.

2018年，API市场价值为1763亿美元（1550亿欧元），预计到2026年将持续增长。

The ResearchAndMarkets report identifies an ageingglobal population and patent expiration on various blockbuster drugs, leadingto the creation and launch of multiple generics and biosimilar competitors, astwo significant factors fuelling this growth.

《研究与市场报告》指出，全球人口老龄化和各种畅销药物的专利到期，导致了多种仿制药和生物仿制药竞争对手的创建和推出，这是推动这一增长的两个重要因素。

The report points to figures published by the WHO, which identifiesthe over 60 age group as set to become 22% of the total global population by2050, up from 12% in 2000. In terms of region, this growth is led by LatinAmerica, Asia and Africa, respectively.

报告指出了世卫组织公布的数据，该组织确定，到2050年，60岁以上的人口将占全球总人口的22%，高于2000年的12%。就地区而言，这一增长分别由拉丁美洲、亚洲和非洲引领。

A similar report, produced by AcumenResearch and Consulting, notes that the NorthAmerican market is the largest due to the high occurrence of diabetes andcancer. Additionally, a high proportion of the population is over 65, at 15.6%in 2017.

Acumen Research and Consulting发布的一份类似报告指出，由于糖尿病和癌症的高发病率，北美市场是最大的。此外，高比例的人口超过65人，2017年为15.6%。

However, the report suggests that themarket in the Asia Pacific region, driven in particular by China and Japan, isgrowing at a faster rate than the global trend, at 8.2% compound annual growthrate (CAGR).

然而，报告指出，亚太地区的市场增长速度比全球趋势更快，尤其是中国和日本，复合年增长率为8.2%。

In addition to the growth of the marketin the region, more companies are expected to set up manufacturing in the AsiaPacific region to capitalise on the growing market and the lower cost oflabour.

除了亚太地区市场的增长外，预计还会有更多的公司在亚太地区建立制造业，以利用不断增长的市场和较低的劳动力成本。

The main disease areas that are fuellingthe growth are in oncology and cardiovascular, with the latter registering thelargest segment of the overall market.

推动增长的主要疾病领域是肿瘤学和心血管，后者是整个市场的最大部分。

Cardiovascular diseaseis the largest cause of death worldwide and generic treatments, such as statinsthat are regularly prescribed to the elderly, are a major contributor to 6%overall CAGR seen in this area. In 2017, medicinal services expenditure forhypertension was approximately $25bn in the ‘developed world’.

心血管疾病是全世界最大的死亡原因，普通疗法，如经常给老年人开的他汀类药物，是该领域总复合年增长率6%的主要原因。2017年，发达国家高血压医疗服务支出约250亿美元。

本文内容取自 in-Pharma Technology

关注PQE，了解最新医药器械行业前沿与法规动向